Ownby Kristin K
UT Health Cizik School of Nursing, Houston, Texas.
J Adv Pract Oncol. 2019 Mar;10(2):175-179. Epub 2019 Mar 1.
Distress is experienced by many cancer patients, adversely affecting quality of life and cancer care. Although it is often manageable, it remains woefully underidentified and underreported. Distress can occur anytime during the cancer experience and is associated with depression, anxiety, missed appointments, and adverse outcomes. In 1999, the National Comprehensive Cancer Network (NCCN), recommended routine screening for distress in all cancer patients. The Distress Thermometer (DT) was developed as a simple tool to effectively screen for symptoms of distress. The instrument is a self-reported tool using a 0-to-10 rating scale. Additionally, the patient is prompted to identify sources of distress using a Problem List. The DT has demonstrated adequate reliability and has been translated into numerous languages. The tool is easy to administer and empowers the clinician to facilitate appropriate psychosocial support and referrals.
许多癌症患者都会经历痛苦,这对生活质量和癌症护理产生不利影响。尽管它通常是可以控制的,但仍然严重未被识别和报告不足。痛苦可能在癌症治疗过程中的任何时候出现,并且与抑郁、焦虑、错过预约以及不良后果相关。1999年,美国国立综合癌症网络(NCCN)建议对所有癌症患者进行痛苦的常规筛查。痛苦温度计(DT)被开发为一种有效筛查痛苦症状的简单工具。该工具是一种自我报告工具,使用0至10的评分量表。此外,还会促使患者使用问题清单来识别痛苦来源。DT已证明具有足够的可靠性,并已被翻译成多种语言。该工具易于使用,使临床医生能够提供适当的心理社会支持并进行转诊。